JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M311591200 on April 12, 2004

J. Biol. Chem., Vol. 279, Issue 25, 26167-26175, June 18, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/25/26167    most recent
M311591200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vruchte, D. t.
Right arrow Articles by Sillence, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vruchte, D. t.
Right arrow Articles by Sillence, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Accumulation of Glycosphingolipids in Niemann-Pick C Disease Disrupts Endosomal Transport*

Danielle te Vruchte{ddagger}, Emyr Lloyd-Evans§, Robert Jan Veldman¶, David C. A. Neville, Raymond A. Dwek, Frances M. Platt, Wim J. van Blitterswijk¶, and Dan J. Sillence§||

From the Glycobiology Institute, Department of Biochemistry, South Parks Road, University of Oxford, Oxford OX1 3QU, United Kingdom and Division of Cellular Biochemistry, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands

Glycosphingolipids are endocytosed and targeted to the Golgi apparatus but are mistargeted to lysosomes in sphingolipid storage disorders. Substrate reduction therapy utilizes imino sugars to inhibit glucosylceramide synthase and potentially abrogate the effects of storage. Niemann-Pick type C (NPC) disease is a disorder of intracellular transport where glycosphingolipids (GSLs) and cholesterol accumulate in endosomal compartments. The mechanisms of altered intracellular trafficking are not known but may involve the mistargeting and disrupted function of proteins associated with GSL membrane microdomains. Membrane microdomains were isolated by Triton X-100 and sucrose density gradient ultracentrifugation. High pressure liquid chromatography and mass spectrometric analysis of NPC1–/– mouse brain revealed large increases in GSL. Sphingosine was also found to be a component of membrane microdomains, and in NPC liver and spleen, large increases in cholesterol and sphingosine were found. GSL and cholesterol levels were increased in mutant NPC1-null Chinese hamster ovary cells as well as U18666A and progesterone induced NPC cell culture models. However, inhibition of GSL synthesis in NPC cells with N-butyldeoxygalactonojirimycin led to marked decreases in GSL but only small decreases in cholesterol levels. Both annexin 2 and 6, membrane-associated proteins that are important in endocytic trafficking, show distorted distributions in NPC cells. Altered BODIPY lactosylceramide targeting, decreased endocytic uptake of a fluid phase marker, and mistargeting of annexin 2 (phenotypes associated with NPC) are reversed by inhibition of GSL synthesis. It is suggested that accumulating GSL is part of a mislocalized membrane microdomain and is responsible for the deficit in endocytic trafficking found in NPC disease.


Received for publication, October 22, 2003 , and in revised form, April 8, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Supported by a grant from Action Medical Research (UK).

§ Supported by grants from the Ara Parseghian Medical Research Foundation.

|| To whom correspondence should be addressed: Glycobiology Institute, Dept. of Biochemistry, South Parks Rd., University of Oxford, Oxford OX1 3QU, UK. Tel.: 44-1865-275743; Fax: 44-1865-275216; E-mail: dan{at}glycob.ox.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
H. Li, S. D. Turley, B. Liu, J. J. Repa, and J. M. Dietschy
GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice
J. Lipid Res., August 1, 2008; 49(8): 1816 - 1828.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. D. Pacheco, R. Kunkel, and A. P. Lieberman
Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects
Hum. Mol. Genet., June 15, 2007; 16(12): 1495 - 1503.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Haidar, R. S. Kiss, L. Sarov-Blat, R. Brunet, C. Harder, R. McPherson, and Y. L. Marcel
Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux
J. Biol. Chem., December 29, 2006; 281(52): 39971 - 39981.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Sagiv, K. Hudspeth, J. Mattner, N. Schrantz, R. K. Stern, D. Zhou, P. B. Savage, L. Teyton, and A. Bendelac
Cutting Edge: Impaired Glycosphingolipid Trafficking and NKT Cell Development in Mice Lacking Niemann-Pick Type C1 Protein
J. Immunol., July 1, 2006; 177(1): 26 - 30.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Kiss, Z. Ma, K. Nakada-Tsukui, E. Brugnera, G. Vassiliou, H. M. McBride, K. S. Ravichandran, and Y. L. Marcel
The Lipoprotein Receptor-related Protein-1 (LRP) Adapter Protein GULP Mediates Trafficking of the LRP Ligand Prosaposin, Leading to Sphingolipid and Free Cholesterol Accumulation in Late Endosomes and Impaired Efflux
J. Biol. Chem., April 28, 2006; 281(17): 12081 - 12092.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Gong, M. Duvvuri, M. B. Duncan, J. Liu, and J. P. Krise
Niemann-Pick C1 Protein Facilitates the Efflux of the Anticancer Drug Daunorubicin from Cells According to a Novel Vesicle-Mediated Pathway
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 242 - 247.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. N. Glaros, W. S. Kim, C. M. Quinn, J. Wong, I. Gelissen, W. Jessup, and B. Garner
Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway: 1-PHENYL-2-DECANOYLAMINO-3-MORPHOLINO-1-PROPANOL IS A NOVEL CHOLESTEROL EFFLUX ACCELERATOR
J. Biol. Chem., July 1, 2005; 280(26): 24515 - 24523.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-Y. Chang, P. C. Reid, S. Sugii, N. Ohgami, J. C. Cruz, and C. C. Y. Chang
Niemann-Pick Type C Disease and Intracellular Cholesterol Trafficking
J. Biol. Chem., June 3, 2005; 280(22): 20917 - 20920.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.